World Cancer Day 2023
World Cancer Day is observed on February 4th every year to raise awareness about the disease and to encourage individuals and organizations to take action to prevent, treat and control it. The day aims to unite the global community in the fight against cancer and to show support to those affected by the disease.
Cancer is a leading cause of death worldwide, with approximately 10 million deaths every year. The disease is caused by the uncontrolled growth of cells in the body, which can invade surrounding tissues and spread to other parts of the body. There are over 100 different types of cancer, each with its own specific symptoms and treatments.
On World Cancer Day, individuals and organizations are encouraged to participate in activities and events to raise awareness about the disease. Social media is a powerful tool for spreading the message about World Cancer Day and its goals.
According to the global statistics, the estimated blended rate of the cancer incidence and mortality for both males and females in all age groups are:
In 2020, the highest cancer incidence was registered in Eastern and South-Central Asia and in North America. The highest mortality was estimated in Eastern Asia and in North America.
In 2023 in the US it is estimated that there will be around two million new cancer cases diagnosed, and 600 000 cancer deaths will ensue.
Battle with Cancer
Prevention is key in the fight against cancer. Simple steps such as maintaining a healthy diet, getting regular exercise, avoiding tobacco and excessive alcohol consumption, and protecting skin from the sun can help reduce the risk of developing certain types of cancer. Regular health screenings and early detection are also important in treating cancer and improving patient outcomes.
In addition to individual efforts, governments and organizations also play a crucial role in the fight against cancer. This can include providing funding for cancer research and education, supporting cancer patients and their families, and advocating for policies that promote cancer prevention and treatment.
While the fight against cancer is ongoing, significant progress has been made in recent years. New treatments and therapies are being developed, and survival rates for many types of cancer are improving.
In 2022, there were some important developments in cancer research. The U.S. Food and Drug Administration (FDA) issued 40 drug approvals for oncology indications, 12 of which were for new molecules.
Clinical Trials in Cancer
The global pharmaceutical industry is constantly conducting new clinical trials aimed to produce better drugs for patients with cancer.
There are currently 30,363 ongoing clinical trials that deal with cancer:
If you would like to learn more about the latest clinical trials and about access to life-saving cancer treatments, here are some helpful links:
- National Cancer Institute
- American Cancer Society
- American Association for Cancer Research
- Centers for Disease Control and Prevention
- American Society for Clinical Oncology
In conclusion, World Cancer Day serves as an important reminder of the impact of cancer on individuals, families, and communities worldwide. By working together, we can raise awareness, reduce the risk of cancer, and improve patient outcomes. On February 4th, let us all take a moment to show support for those affected by cancer and to recommit ourselves to the fight against this disease.
Cromos Pharma has extensive experience in managing all aspects of cancer clinical trials, in all phases, including rescue, post-marketing and observational studies. Oncology trials represent a substantial part of the company’s research portfolio.
About Cromos Pharma
Cromos Pharma is a US-based, midsized international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.
Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing multicountry trials of novel therapeutics. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data. Cromos Pharma combines global expertise with in-depth local experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye assuring rapid patient recruitment.
Our team has met or reduced enrollment timelines in 95% of conducted trials. Established in 2004, Cromos Pharma’s international HQ is in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.
If you have any questions or want to find out more about how Cromos Pharma can support your next clinical program, please get in touch with us by emailing firstname.lastname@example.org